Company Filing History:
Years Active: 2015-2021
Title: Atsuo Yonezawa: Innovator in Antibody Development
Introduction
Atsuo Yonezawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 4 patents to his name, Yonezawa's work is paving the way for advancements in therapeutic applications.
Latest Patents
Yonezawa's latest patents include a novel bispecific antibody format. This invention addresses the problem of creating a bispecific antibody that retains high binding affinity to both antigens while being efficiently produced in a commercial setting. The antibody comprises two heavy chains and two light chains, forming distinct antigen binding sites that recognize different antigens. Another significant patent involves an anti-human IL-23 receptor antibody. This invention aims to provide an antibody with superior activity and cross-reactivity compared to existing IL-23R antibodies, with potential applications in treating diseases such as inflammatory bowel disease and psoriasis.
Career Highlights
Atsuo Yonezawa is currently employed at Astellas Pharma GmbH, where he continues to innovate in the field of antibody research. His work is instrumental in developing therapies that target specific diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Yonezawa collaborates with notable colleagues, including Masazumi Kamohara and Hirotsugu Tanaka. Their combined expertise enhances the research and development efforts at Astellas Pharma GmbH.
Conclusion
Atsuo Yonezawa's contributions to the field of biotechnology, particularly in antibody development, highlight his role as a leading inventor. His innovative patents are set to make a significant impact on therapeutic strategies in the medical field.